Hark Kyun Kim, Jeong Won Kang, Young‐Whan Park, Jung Young Kim, Minchae Kim, Soo Jin Kim, . . . Joong‐Won Park. (2020). Phase I and pharmacokinetic study of the vascular‐disrupting agent CKD‐516 (NOV120401) in patients with refractory solid tumors. Wiley.
Chicago Style (17th ed.) CitationHark Kyun Kim, et al. Phase I and Pharmacokinetic Study of the Vascular‐disrupting Agent CKD‐516 (NOV120401) in Patients with Refractory Solid Tumors. Wiley, 2020.
MLA (9th ed.) CitationHark Kyun Kim, et al. Phase I and Pharmacokinetic Study of the Vascular‐disrupting Agent CKD‐516 (NOV120401) in Patients with Refractory Solid Tumors. Wiley, 2020.
Warning: These citations may not always be 100% accurate.